Clinical Trials Directory

Trials / Completed

CompletedNCT06102135

Acceptability and Tolerance Study of Peptide Feed with Fibre

To Evaluate the Acceptability (including Gastrointestinal Tolerance and Compliance) of an Adult Peptide 1.3 Kcal/ml Tube-feed Formula Containing Partially Hydrolysed Guar Gum (PHGG) Fibre.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Enterally fed adults with documented evidence of gastrointestinal intolerance will be recruited. Participants will be deemed by the investigator as having a clinical indication for enteral feeding with a fibre containing peptide formula. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.

Detailed description

To evaluate the acceptability (including gastrointestinal tolerance and compliance) of an adult enteral peptide formula containing Partially Hydrolysed Guar Gum (PHGG) fibre in 15 patients. This is a single arm, prospective, multi-centre study to evaluate the gastrointestinal tolerance and compliance over a fourteen-day period. Data will be collected using patient diaries to asses changes in GI tolerance and tube feed intake.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPeptamen 1.3 PHGGThe amount of tube feed will be assess by the health Care Professional.

Timeline

Start date
2023-09-05
Primary completion
2024-09-03
Completion
2024-09-03
First posted
2023-10-26
Last updated
2024-09-23

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06102135. Inclusion in this directory is not an endorsement.